Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of WH007 in the Treatment of Polycystic Ovary Syndrome (PCOS) (China)

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of WH007 in the Treatment of Polycystic Ovary Syndrome (PCOS)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130343

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329718

Published by HT Digital Content Services with permission from Health Daily Digest....